ATE16244T1 - Verfahren zur herstellung von kapselpolyosiden, so erhaltene kapselpolyosiden und ihre verwendung fuer die herstellung von vakzinen. - Google Patents
Verfahren zur herstellung von kapselpolyosiden, so erhaltene kapselpolyosiden und ihre verwendung fuer die herstellung von vakzinen.Info
- Publication number
- ATE16244T1 ATE16244T1 AT82401343T AT82401343T ATE16244T1 AT E16244 T1 ATE16244 T1 AT E16244T1 AT 82401343 T AT82401343 T AT 82401343T AT 82401343 T AT82401343 T AT 82401343T AT E16244 T1 ATE16244 T1 AT E16244T1
- Authority
- AT
- Austria
- Prior art keywords
- polyosides
- production
- capsular
- bacteriae
- give
- Prior art date
Links
- 238000004519 manufacturing process Methods 0.000 title abstract 4
- 238000000034 method Methods 0.000 title abstract 3
- 239000002775 capsule Substances 0.000 title 2
- 229960005486 vaccine Drugs 0.000 title 1
- 239000000463 material Substances 0.000 abstract 6
- 230000000813 microbial effect Effects 0.000 abstract 4
- 230000000717 retained effect Effects 0.000 abstract 4
- 238000001914 filtration Methods 0.000 abstract 2
- 230000002163 immunogen Effects 0.000 abstract 2
- 150000002632 lipids Chemical class 0.000 abstract 2
- 239000007791 liquid phase Substances 0.000 abstract 2
- 239000012528 membrane Substances 0.000 abstract 2
- 102000039446 nucleic acids Human genes 0.000 abstract 2
- 108020004707 nucleic acids Proteins 0.000 abstract 2
- 150000007523 nucleic acids Chemical class 0.000 abstract 2
- 102000004169 proteins and genes Human genes 0.000 abstract 2
- 108090000623 proteins and genes Proteins 0.000 abstract 2
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/02—Bacterial antigens
- A61K39/025—Enterobacteriales, e.g. Enterobacter
- A61K39/0266—Klebsiella
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/02—Bacterial antigens
- A61K39/09—Lactobacillales, e.g. aerococcus, enterococcus, lactobacillus, lactococcus, streptococcus
- A61K39/092—Streptococcus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/02—Bacterial antigens
- A61K39/102—Pasteurellales, e.g. Actinobacillus, Pasteurella; Haemophilus
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P19/00—Preparation of compounds containing saccharide radicals
- C12P19/04—Polysaccharides, i.e. compounds containing more than five saccharide radicals attached to each other by glycosidic bonds
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Microbiology (AREA)
- General Health & Medical Sciences (AREA)
- Epidemiology (AREA)
- Mycology (AREA)
- Pharmacology & Pharmacy (AREA)
- Organic Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Immunology (AREA)
- Engineering & Computer Science (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Biotechnology (AREA)
- Biochemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Engineering & Computer Science (AREA)
- Genetics & Genomics (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Polyesters Or Polycarbonates (AREA)
- Medicinal Preparation (AREA)
- Compounds Of Unknown Constitution (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Peptides Or Proteins (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FR8114842A FR2510606A1 (fr) | 1981-07-30 | 1981-07-30 | Procede d'obtention de polyosides capsulaires, polyosides capsulaires ainsi obtenus et leur application a la preparation de vaccins |
| EP82401343A EP0071515B1 (fr) | 1981-07-30 | 1982-07-19 | Procédé d'obtention de polyosides capsulaires, polyosides capsulaires ainsi obtenus et leur application à la préparation de vaccins |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE16244T1 true ATE16244T1 (de) | 1985-11-15 |
Family
ID=9261011
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT82401343T ATE16244T1 (de) | 1981-07-30 | 1982-07-19 | Verfahren zur herstellung von kapselpolyosiden, so erhaltene kapselpolyosiden und ihre verwendung fuer die herstellung von vakzinen. |
Country Status (11)
| Country | Link |
|---|---|
| EP (1) | EP0071515B1 (enExample) |
| AT (1) | ATE16244T1 (enExample) |
| CA (1) | CA1206905A (enExample) |
| DD (1) | DD202623A5 (enExample) |
| DE (1) | DE3267160D1 (enExample) |
| DK (1) | DK327182A (enExample) |
| ES (1) | ES8305827A1 (enExample) |
| FR (1) | FR2510606A1 (enExample) |
| IE (1) | IE53582B1 (enExample) |
| NO (1) | NO159394C (enExample) |
| PT (1) | PT75301B (enExample) |
Families Citing this family (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0238739B1 (en) * | 1986-03-27 | 1992-02-05 | Swiss Serum and Vaccine Institute Berne | Klebsiella capsular polysaccharide vaccine |
| US6426074B1 (en) * | 1997-03-19 | 2002-07-30 | The Brigham And Women's Hospital Inc. | Group B Streptococcus vaccine |
| KR20080081978A (ko) * | 2000-03-16 | 2008-09-10 | 더 칠드런스 호스피탈 오브 필라델피아 | 폐렴구균의 캡슐 다당류 생산의 조절 방법 |
| NZ511680A (en) | 2001-05-14 | 2004-07-30 | Univ Waikato | Method for preparing nucleic acid or DNA samples and a DNA extraction process using thermophilic proteases |
| GB0522303D0 (en) * | 2005-11-01 | 2005-12-07 | Chiron Srl | Culture method |
| US8398985B2 (en) | 2007-04-23 | 2013-03-19 | Serum Institute Of India Ltd. | Antigenic polysaccharides and process for their preparation |
| WO2011148382A1 (en) | 2010-05-28 | 2011-12-01 | Biological E Limited | An improved process for the purification of capsular polysaccharides of haemophilus influenza - b, neisseria meningitis such as serotypes a, c, y and w-135, and other similar related capsular polysaccharides produced from both gram negative and gram positive microorganisms using aluminium phosphate with alcohol. |
| WO2011151841A1 (en) * | 2010-05-31 | 2011-12-08 | Panacea Biotec Limited | Fermentation process for streptococcus pneumoniae |
| US11951165B2 (en) | 2016-12-30 | 2024-04-09 | Vaxcyte, Inc. | Conjugated vaccine carrier proteins |
| KR20190103256A (ko) | 2016-12-30 | 2019-09-04 | 수트로박스, 인코포레이티드 | 비자연 아미노산을 갖는 폴리펩타이드-항원 접합체 |
| WO2020010016A1 (en) | 2018-07-04 | 2020-01-09 | Sutrovax, Inc. | Self-adjuvanted immunogenic conjugates |
| JP2025531339A (ja) | 2022-09-19 | 2025-09-19 | バイオロジカル イー リミテッド | 莢膜ポリサッカライドの精製法 |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US2166963A (en) * | 1936-11-19 | 1939-07-25 | Sharp & Dohme Inc | Antigenic polysaccharide complex |
| US2528972A (en) * | 1947-05-15 | 1950-11-07 | Western Reserve University | Prophylactic toxoid compound and method of making same |
| FR2407262A1 (fr) * | 1977-10-27 | 1979-05-25 | Cassenne Lab Sa | Nouveaux polysaccharides extraits de corps microbiens d'haemophilus influenzae, procede de preparation et application a titre de medicaments de ces nouveaux produits |
| CA1115210A (en) * | 1977-11-28 | 1981-12-29 | Dennis J. Carlo | Pneumococcal vaccine |
| US4264764A (en) * | 1979-01-12 | 1981-04-28 | Merck & Co., Inc. | Meningitis vaccine |
| US4221906A (en) * | 1979-03-19 | 1980-09-09 | American Cyanamid Company | Stabilization of pneumococcal polysaccharides |
| US4287173A (en) * | 1979-09-24 | 1981-09-01 | Merck & Co., Inc. | Vaccine for dental caries |
| US4307080A (en) * | 1979-09-24 | 1981-12-22 | Merck & Co., Inc. | Meningitis vaccine |
-
1981
- 1981-07-30 FR FR8114842A patent/FR2510606A1/fr active Granted
-
1982
- 1982-07-15 IE IE1705/82A patent/IE53582B1/en unknown
- 1982-07-19 EP EP82401343A patent/EP0071515B1/fr not_active Expired
- 1982-07-19 AT AT82401343T patent/ATE16244T1/de not_active IP Right Cessation
- 1982-07-19 DE DE8282401343T patent/DE3267160D1/de not_active Expired
- 1982-07-21 DK DK327182A patent/DK327182A/da not_active Application Discontinuation
- 1982-07-23 PT PT75301A patent/PT75301B/pt not_active IP Right Cessation
- 1982-07-28 CA CA000408233A patent/CA1206905A/en not_active Expired
- 1982-07-28 NO NO822592A patent/NO159394C/no unknown
- 1982-07-29 DD DD82242065A patent/DD202623A5/de unknown
- 1982-07-29 ES ES514496A patent/ES8305827A1/es not_active Expired
Also Published As
| Publication number | Publication date |
|---|---|
| EP0071515B1 (fr) | 1985-10-30 |
| FR2510606B1 (enExample) | 1984-10-26 |
| NO159394B (no) | 1988-09-12 |
| DK327182A (da) | 1983-01-31 |
| PT75301A (fr) | 1982-08-01 |
| FR2510606A1 (fr) | 1983-02-04 |
| IE53582B1 (en) | 1988-12-21 |
| NO159394C (no) | 1988-12-21 |
| DE3267160D1 (en) | 1985-12-05 |
| EP0071515A1 (fr) | 1983-02-09 |
| PT75301B (fr) | 1984-07-31 |
| NO822592L (no) | 1983-01-31 |
| DD202623A5 (de) | 1983-09-28 |
| ES514496A0 (es) | 1983-04-16 |
| CA1206905A (en) | 1986-07-02 |
| IE821705L (en) | 1983-01-30 |
| ES8305827A1 (es) | 1983-04-16 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ATE91155T1 (de) | Verfahren zur bereitung von nukleinsaeure fuer hybridisierung. | |
| ATE16244T1 (de) | Verfahren zur herstellung von kapselpolyosiden, so erhaltene kapselpolyosiden und ihre verwendung fuer die herstellung von vakzinen. | |
| DE3784860D1 (de) | Verbessertes verfahren zur transformation von pflanzlichen protoplasten. | |
| DE69114311D1 (de) | Verfahren zur Herstellung und Extrahierung von Antioxydantien aus einer Mikroorganismenkultur und Fotobioreaktor zur Durchführung des Verfahrens. | |
| EP0387567A3 (en) | Amphoteric polyelectrolyte, method for production thereof, and organic sludge dehydrater | |
| DE69112463D1 (de) | Vorrichtung zur Herstellung von Monokristallen nach dem Czochralski-Verfahren. | |
| ATE18776T1 (de) | Verfahren und vorrichtung zur zuechtung von mikroorganismen. | |
| DE69109886D1 (de) | Verfahren zur Herstellung von humanem Faktor VIII und dessen Analogen. | |
| FR2545099B1 (fr) | Nouvelle souche de trichoderma harzianum procede d'isolement de cette souche, procede de culture de cette souche, nouveaux peptides produits par cette souche, et application de cette souche et ces nouveaux peptides ou du produit obtenu par le procede de culture comme moyen de lutte biologique sous forme de produit phytosanitaire | |
| PT80542A (de) | Gentechnologisches verfahren zur herstellung von human-interleukin-2 und mittel zur durchfuehrung dieses verfahrens | |
| ATE220714T1 (de) | Verfahren zur herstellung von proteinen | |
| ATE9100T1 (de) | Trichosporon kashiwayama ifo 1964, kulturbruehe, zell-freie sterile fluessigkeit, steriles filtrat, steriler ueberstand, steriles konzentrat und steriles trockenprodukt einer kulturbruehe, verfahren zur herstellung einer kulturbruehe, pharmazeutische zusammensetzung, kosmetische zusammensetzung. | |
| DE68912236D1 (de) | Verfahren zur Herstellung von hochgradig ungesättigten Fettsäuren. | |
| EP0391345A3 (en) | Method for preparing optically active substances | |
| AT361906B (de) | Verfahren zur herstellung von neuen 2,4,6- trijodbenzonitrilen sowie deren estern, saeure- amiden und salzen | |
| DE68904131D1 (de) | Schweinenierenzellkultur und ihre verwendung fuer die herstellung von vakzinen. | |
| DE69116240D1 (de) | Verfahren zur Herstellung von Zellprotein mit Anti-HIV-Wirkung | |
| ATE21033T1 (de) | Verfahren zur herstellung eines immunogens aus pasteurella multocida. | |
| ATE112170T1 (de) | Verfahren zur herstellung und reinigung von hepatitis b-impfstoff. | |
| ATE60190T1 (de) | Verfahren zum regenerieren von mais. | |
| DE69015499D1 (de) | Verfahren zur Herstellung von Castanosperminestern. | |
| ATE2339T1 (de) | Verfahren zur herstellung von sphingomyelinase, sphingomyelinase und deren verwendung. | |
| ATE118248T1 (de) | 5'-phosphodiesterase-enzymzubereitung und verfahren zur herstellung. | |
| JPS5675095A (en) | Preparation of heat-resistant acetic acid kinase | |
| RU93028311A (ru) | Способ получения биологически активных веществ из биомассы культивируемых клеток растений |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| UEP | Publication of translation of european patent specification | ||
| REN | Ceased due to non-payment of the annual fee |